# Truepill

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/truepill

- Industry: Healthcare IT
- Headquarters: Hayward, US
- Website: www.truepill.com
- Total disclosed funding: $280M
- Latest round: Series D (Oct 14, 2021)
- Investors on record: 9

## About

Truepill, Inc. is a US-based digital pharmacy platform enhancing patient and healthcare provider experiences by delivering medications efficiently through innovative technology and logistics solutions.Truepill, Inc. operates as a digital pharmacy that focuses on improving the pharmacy experience for patients and healthcare providers. Founded in 2016 in Hayward, US by entrepreneurs Sid Viswanathan and Umar Afridi, the company has successfully adapted its business strategy to leverage technology in healthcare. Truepill has completed 7 deals to date, with the most recent investment round being an Add-on of USD 25.0 mn from LetsGetChecked on October 1, 2024, bringing the total amount raised to USD 142.5 mn.Truepill offers a comprehensive digital pharmacy platform designed to enhance pharmacy operations for healthcare providers and patients. Its core offerings include a B2B pharmacy solution that enables clients to build, manage, and scale their pharmacy services through APIs and a pre-built Virtual Pharmacy solution. This platform supports various functionalities, such as payment options and shipping configurations, while maintaining a nationwide reach through URAC-accredited pharmacies that cater to a diverse clientele, including healthcare innovators and life sciences companies.Truepill generates revenue primarily through partnerships with healthcare organizations and B2B clients utilizing its digital pharmacy capabilities. The company engages in structured transactions involving service agreements for virtual pharmacy integration, which may include subscription-based pricing for API access and fulfillment service fees. This model positions Truepill as a vital partner in the healthcare supply chain, enhancing operational efficiency and patient engagement.Following its recent acquisition by LetsGetChecked for USD 25 mn in cash, with an additional USD 200 mn contingent upon revenue milestones, Truepill plans to expand its healthcare solutions from testing to treatment. The acquisition aims to foster comprehensive healthcare offerings, indicating strategic growth into related services and regions as well as leveraging the technological synergies with LetsGetChecked. Future initiatives will likely include the development of new products designed to integrate further into the healthcare ecosystem.

## Funding rounds

- Series D, Oct 14, 2021, $143M — Initialized Capital, Transpose Platform Management
- Series C, Aug 26, 2020, $76M — Y Combinator, Kaiser Foundation Hospitals, Trusted Insight, Inc., Sound Ventures, Oak HC/FT, Optum Ventures
- Series B, Jul 8, 2020, $25M — Initialized Capital, Trusted Insight, Inc., Sound Ventures, Optum Ventures
- Series B, Dec 2, 2019, $23M — Initialized Capital, Sound Ventures, Transpose Platform Management, Optum Ventures
- Series A, Mar 12, 2019, $13M — Y Combinator, Tuesday Capital, Initialized Capital, Sound Ventures

## Investors

- Y Combinator (https://capitalatlas.ai/funds/y-combinator) — Series A, Series C
- Tuesday Capital (https://capitalatlas.ai/funds/tuesday-capital) — Series A
- Initialized Capital (https://capitalatlas.ai/funds/initialized-capital) — Series A, Series B, Series D
- Sound Ventures (https://capitalatlas.ai/funds/sound-ventures) — Series A, Series B, Series C
- Transpose Platform Management (https://capitalatlas.ai/funds/transpose-platform-management) — Series B, Series D
- Optum Ventures (https://capitalatlas.ai/funds/optum-ventures) — Series B, Series C
- Trusted Insight, Inc. — Series B, Series C
- Kaiser Foundation Hospitals — Series C
- Oak HC/FT (https://capitalatlas.ai/funds/oak-hc-ft) — Series C
